Ocular Therapeutix Inc (NASDAQ: OCUL) reported first quarter EPS of $-0.29, $0.04 worse than the analyst estimate of $-0.25. Revenue for the quarter came in at $17.08M versus the consensus estimate of $17.21M.
Ocular Therapeutix Inc's stock price closed at $7.14. It is down -22.22% in the last 3 months and down -34.38% in the last 12 months.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.